Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
33.57 USD | +0.84% | +1.16% | +5.14% |
Jul. 10 | Merck KGaA: share price down, analyst lowers target | CF |
Jul. 10 | MERCK KGAA : UBS lowers price target | CF |
Sales 2024 * | 21.3B 23.23B | Sales 2025 * | 22.55B 24.59B | Capitalization | 67.06B 73.14B |
---|---|---|---|---|---|
Net income 2024 * | 2.98B 3.25B | Net income 2025 * | 3.52B 3.84B | EV / Sales 2024 * | 3.45 x |
Net Debt 2024 * | 6.44B 7.02B | Net Debt 2025 * | 4.63B 5.05B | EV / Sales 2025 * | 3.18 x |
P/E ratio 2024 * |
22.5
x | P/E ratio 2025 * |
18.9
x | Employees | 62,345 |
Yield 2024 * |
1.51% | Yield 2025 * |
1.65% | Free-Float | 29.71% |
Latest transcript on Merck KGaA
1 day | +0.84% | ||
1 week | +1.16% | ||
Current month | +1.24% | ||
1 month | -11.81% | ||
3 months | +3.32% | ||
6 months | +5.14% | ||
Current year | +5.14% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | 20-07-12 | |
Marcus Kuhnert
DFI | Director of Finance/CFO | 56 | 14-07-31 |
Director of Finance/CFO | 54 | 19-04-25 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 75 | 14-05-08 | |
Christian Raabe
BRD | Director/Board Member | - | - |
Chairman | 67 | 19-04-25 |
Date | Price | Change | Volume |
---|---|---|---|
24-07-12 | 33.57 | +0.84% | 40,922 |
24-07-11 | 33.29 | +2.76% | 20,162 |
24-07-10 | 32.4 | +0.02% | 23,021 |
24-07-09 | 32.39 | -0.86% | 27,883 |
24-07-08 | 32.67 | -1.55% | 33,511 |
Delayed Quote OTC Markets, July 12, 2024 at 03:59 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.10% | 10.38B | |
+37.94% | 5.16B | |
-17.33% | 4.73B | |
+21.49% | 3.81B | |
+24.92% | 2.26B | |
-36.84% | 1.88B | |
-43.31% | 1.77B | |
-0.50% | 1.64B | |
-1.11% | 1.57B |
- Stock Market
- Equities
- MRK Stock
- MKKGY Stock